That’s a wrap on our final DECISION GA! From COMBAT & PROSPECT updates to forward-looking discussions and feedback, we’re proud of our shared achievements and motivated to keep advancing ACLF & decompensated cirrhosis research together. #LiverTwitter

Our final GA is a look back and forward - from major scientific milestones to future discoveries! After a keynote by Prof. Rubén Francés, partners shared results on omics integration, biomarkers & systems medicine - and closed with a masterclass on data repositories. #cirrhosis

Next week: the final DECISION General Assembly in Madrid! 🎉 Celebrating 5+ years of science, collaboration, and results. @ef_clif @RautouE @AnnaBoschComas @DrAAlbillos @rajmookerjee @Unipd_Medicina @EASLnews @EuropeLiver @MEDB_LAB and many more!

The latest DECISION Masterclass is live! 💡 Clinical Bioinformatics – It’s More Than Pressing a Button with Núria Planell, Cristina Sanchez & David Gomez-Cabrero. Watch here: https://t.co/AH1lUYGnsj #Bioinformatics #ClinicalResearch #ACLF

Today is #WorldHepatitisDay! We spotlight two DECISION partners deeply committed to #liverhealth: 🔬 @EASLnews – advancing #hepatology research 🧡 @EuropeLiver – amplifying the voice of liver patients Together, we work toward a healthier future beyond ACLF. #Cirrhosis

🔥 We’ve hit 50% recruitment in the #COMBATtrial! Huge thanks to all involved!💙 @RautouE @ef_clif @hospitalclinic @LiverIcu @UniklinikAachen @Unibo @Zac_MD @DrAAlbillos @unito @VHIR_ @APHP @UK_Muenster @MEDB_LAB @UschnerFrank @rajmookerjee #LiverTwitter #ACLF #ClinicalTrials

🎥 New keynote online! Prof. Richard Moreau, Director of @ef_clif, explores immune dysfunction in AD & #ACLF and suggests a common mechanism behind inflammation & immune deficiency. Watch now 👉 https://t.co/fow9NOhT07 #LiverTwitter #Hepatology

🎉 Exciting news: We’ve surpassed 500 followers on @LinkedIn! Follow us there for updates on trials, science, and more 👉 https://t.co/hsxVov4ZBl #ClinicalResearch #DECISIONproject

Consider joining this event by A-TANGO and @Crowdhelix! "Industrial Perspective on Drug Development Challenges for Clinical Trials" 📅 4th June 2025 🕚 11:00 am CEST / 🕙 10:00 am BST You can register via this link:

It’s #ClinicalTrialsDay! At DECISION, we’re proud of our COMBAT & PROSPECT trials advancing care in decompensated cirrhosis. 💡COMBAT Q&A videos in multiple languages help engage patients ➡️ https://t.co/1Y6xLkwb8z Thanks to all who make our trials possible! #LiverResearch

Clinical trajectories of patients with cirrhosis and ascites receiving long-term albumin #POSTER SAT-145-YI by Enrico Pompili (UNIBO) proposes a personalized management approach for patients w. cirrhosis &ascites, based on real-world data from long-term albumin therapy. #EASL2025

Impact of diabetes mellitus on clinical outcomes in patients with acutely decompensated cirrhosis #E_POSTER by Mimma Bonomo (UNITO) explores how coexisting diabetes mellitus affects prognosis in patients hospitalized with acute decompensation of cirrhosis #EASL2025 @EASLnews

🦠The recovery failure of fecal microbiota diversity in patients after liver transplant is associated with a complicated postoperative course #POSTER SAT-518 by Maike Rebecca Pollmanns from @UniklinikAachen at #EASL2025 @tony_bruns @EASLnews

🧪 Acute kidney disease in acutely decompensated cirrhosis: impact on clinical outcomes #POSTER SAT-122-YI by @AlbCalle (UNITO) examines how acute kidney disease affects outcomes in patients w. acutely decompensated cirrhosis. 📅 Presented at #EASLCongress | #EASL2025 @EASLnews

@RautouE

❤️Cardiac performance is impaired in patients with proven alcohol-related hepatitis and predicts 3-month mortality in this patient population #POSTER SAT-503-YI by Pierre-Emmanuel Rautou (@Inserm, APHP, EF CLIF) 📅 Presented at the #EASLCongress | #EASL2025 @EASLnews

Back in the Abstract Session: Theresa Wirtz presents her scRNA-seq work on monocyte subsets and ACLF risk. @UniklinikAachen @tony_bruns @EASLnews #Cirrhosis #ACLF #EASL2025

Estefania Huergo presents methylation data in AD patients, selected as best Young Investigator abstract in Basic Science at #EASL2025 - Congrats! 🎉 @navarrabiomed @EASLnews #Epigenetics #LiverResearch #EASL2025

Javier Fernandez (FCRB) is giving the hepatologist perspective on management of MDR infections in cirrhosis as part of the EASL/ESCMID Symposium: MDR infections - a challenge in decompensated cirrhosis at #EASL2025 #LiverDisease #Cirrhosis #Hepatology @EASLnews

Is the etiological work-up of #PSVD a one-size-fits-all? DECISION consortium member Lucile Moga from APHP takes part in EASL/ VALDIG's session on "Do's and Don'ts in the management of Porto-Sinusoidal Vascular Disease". #EASLCongress #EASL2025 #LiverResearch @EASLnews